Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy

Combination chemotherapy is widely exploited for suppressing drug resistance and achieving synergistic anticancer efficacy in the clinic. In this paper, the nanostructured targeting methotrexate (MTX) plus pemetrexed (PMX) chitosan nanoparticles (CNPs) were developed by modifying methoxy polye (thyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Juan, Yang, Xiaobing, Huang, Liuqing, Lai, Huixian, Gan, Chuanhai, Luo, Xuetao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263111/
https://www.ncbi.nlm.nih.gov/pubmed/30472899
http://dx.doi.org/10.1080/10717544.2018.1477856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263111/
https://www.ncbi.nlm.nih.gov/pubmed/30472899
http://dx.doi.org/10.1080/10717544.2018.1477856

Ejemplares similares